CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Return on equity 2016–2025
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-4.6%FY2025 · since FY2016: 18.5% → -4.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4.6% | -5.2 pp |
| FY2024 | 0.6% | -12.6 pp |
| FY2023 | 13.2% | -3.1 pp |
| FY2022 | 16.3% | +0.9 pp |
| FY2021 | 15.4% | -1.8 pp |
| FY2020 | 17.2% | +1.8 pp |
| FY2019 | 15.4% | -1.8 pp |
| FY2018 | 17.2% | +5.4 pp |
| FY2017 | 11.8% | -6.7 pp |
| FY2016 | 18.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice